However, your healthcare provider may modify this timeline based on your individual response
Those in the trial that did experience negative side effects did so at the same rate and consistency as those previously reported for injectable GLP-1 drugs and Eli Lilly said it "was consistent." The drugmaker said the most commonly reported negative side effects were mild to moderate gastrointestinal-related symptoms, such as nausea, constipation, indigestion, diarrhea and vomiting
These favorable results require further clinical trials in order to elucidate whether these effects will result or not in reduced mortality
This means: You burn fewer calories at rest Youre more prone to retaining water and fat Weight loss is slower, even with reduced caloric intake Studies suggest that untreated hypothyroidism can blunt the metabolic benefits of weight-loss interventions, including medication
Dose escalation and what to expect at each level GLP-1 therapy always begins with a lower dose and escalates over weeks to months
The consistent pharmacokinetic profile across injection sites simplifies administration for patients, allowing them to choose sites based on comfort, convenience, and proper rotation practices
